Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients

Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients

To determine whether administration of estrogen or gestagen prior to luteinizing hormone-releasing hormone (LH-RH) agonist prevents disease flare in prostate cancer patients, we pretreated the patients with either diethylstilbestrol diphosphate (DES-P) 300 mg daily (N = 17) or chlormadinone acetate...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 46(2000), 8 vom: 01. Aug., Seite 531-6
1. Verfasser: Ohuchi, H (VerfasserIn)
Weitere Verfasser: Noguchi, K, Kinoshita, Y, Hosaka, M, Kawasaki, C, Miura, T, Kondo, I, Harada, M
Format: Aufsatz
Sprache:English
Veröffentlicht: 2000
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Journal Article Multicenter Study Randomized Controlled Trial Antineoplastic Agents, Hormonal Autacoids Progesterone Congeners Chlormadinone Acetate 0SY050L61N Testosterone mehr... 3XMK78S47O Diethylstilbestrol 731DCA35BT Luteinizing Hormone 9002-67-9 fosfestrol A0E0NMA80F Prostate-Specific Antigen EC 3.4.21.77 Leuprolide EFY6W0M8TG